Medical News

RSS

Life Technologies reports third quarter 2009 results; non-GAAP and organic revenues increase by 3% and 5%

Life Technologies Corporation (NASDAQ:LIFE) today announced results for its third quarter ended September 30, 2009. Non-GAAP revenue for the third quarter was $805 million, an increase of 3 percent over third quarter revenue of $784 million in 2008, as if Invitrogen and Applied Biosystems had been combined.

From Danaher 27 Oct 2009

Climate change and public health: only fives states have published public health response plans, says study

Trust for America's Health (TFAH) released a new report today that finds only five states have published a strategic climate change plan that includes a public health response. This includes planning for health challenges and emergencies expected to develop from natural disasters, pollution, and infectious diseases as temperatures and sea levels rise.

27 Oct 2009

New hygienic cutlery dispenser, DIXIE SmartStock, aids in fight against germs

Flu season is in full swing, and high-traffic establishments such as foodservice facilities must take preventive measures to ensure a hygienic and safe environment for their customers. Georgia-Pacific Professional Food Services Solutions is aiding in the fight against germs with its hygienic cutlery dispenser, DIXIE® SmartStock®.

27 Oct 2009

Millennium Research Group to introduce bone morphogenetic proteins in South Korea

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, despite controversy surrounding bone morphogenetic proteins (BMPs) in the US, they will be introduced into South Korea over the next year and experience double-digit growth in Australia, driving the Asia Pacific bone graft substitute market through 2013.

27 Oct 2009

Kansas to introduce constitutional amendment to protect individual rights to purchase health insurance

The American Legislative Exchange Council (ALEC), the nation's largest individual membership association of state legislators, congratulates Kansas Representatives Peggy Mast and Brenda Landwehr and Kansas Senator Mary Pilcher Cook for announcing their intent to introduce a constitutional amendment to protect the right of individuals to make their own health care choices. Kansas now becomes the 19th state where legislators have introduced, or will introduce, legislation modeled after ALEC's Freedom of Choice in Health Care Act.

27 Oct 2009

A new choice in healthcare for residents of Chicago's suburbs

A new choice in healthcare is coming to residents of Chicago's suburbs. Santiago A. Candocia, M.D. and Richard Stern, M.D., of Winnetka and Stewart Segal, M.D. of Lake Zurich, are now part of the growing number of physicians across the nation to offer a new healthcare option to patients: the hybrid model of concierge care.

27 Oct 2009

Astellas enters into agreement with Medivation to develop MDV3100

Astellas Pharma Inc. ("Astellas") and Medivation, Inc. announced today that they have entered into a global agreement to develop and commercialize MDV3100, Medivation's investigational drug for the treatment of prostate cancer.

27 Oct 2009

New systematic study for managing treatment-resistant bipolar depression

Depression in bipolar illness is often difficult to treat and life-threating. Frequently it fails to respond to standard treatments. In the current issue of Psychotherapy and Psychosomatics a new drug combination is suggested.

27 Oct 2009

Issues inside health care not addressed in health care reform

Everyone is talking about health care reform but no one is addressing the inside of health care, where the problems really lie. The question we should be asking is: Can you really trust your doctors and their staff to do what's right for you?

27 Oct 2009

PolyMedix completes second successful clinical study of PMX-60056

PolyMedix, Inc. (http://polymedix.com), an emerging biotechnology company developing new therapeutic drug products to treat infectious diseases and acute cardiovascular disorders, has completed a second successful clinical study of its anticoagulant reversing agent, PMX-60056.

27 Oct 2009

Hospira announces fiscal 2009 third-quarter results

Hospira, Inc., a leading global specialty pharmaceutical and medication delivery company, today reported results for the third quarter ended Sept. 30, 2009. Net sales for the quarter were $1.0 billion, and adjusted diluted earnings per share were $0.90.

27 Oct 2009

New guidebook for long term care planning

The good news is that Americans are living longer. The bad news is that millions are outliving their money; and when they need long term care, they face bleak prospects. According to a new guidebook from LTC Financial Partners, LLC (LTCFP), the unprepared are either forced to move into a nursing home funded by Medicaid, or to live with relatives who must disrupt their lives to care for them.

27 Oct 2009

Metabolon raises additional $6 million in its Series C funding round

Metabolon, Inc., the leader in metabolomics-driven biomarker discovery and analysis, announced today that it has closed an additional $6 million in its Series C funding round. This brings the total funding raised in the company’s series C round to $12.3 million.

27 Oct 2009

New study reveals the importance of bowel preparation prior to procedure

While there is little doubt concerning the effectiveness of colonoscopy procedures to detect colon cancer, a new study presented at the American College of Gastroenterology's 74th Annual Scientific Meeting in San Diego places new emphasis on the importance of adequate bowel preparation prior to procedure.

27 Oct 2009

Waters announces third quarter 2009 sales; foreign currency translation impacts sales growth

Waters Corporation reported today third quarter 2009 sales of $374 million, a decrease of 3% over sales of $386 million in the third quarter of 2008.

27 Oct 2009

Boston Medical Center deploys Fusionfx Immunization Management portal to manage H1N1 vaccination

Acknowledging the critical role of Centers for Disease Control and Prevention (CDC) guidelines in ensuring the safety and efficacy of H1N1 vaccinations, Carefx Corporation, a leading provider of interoperable workflow solutions to advance the quality and safety of patient care, today announced that Boston Medical Center (BMC) has deployed the Fusionfx Immunization Management portal designed to enter and track H1N1 vaccination administration history and support broad, community-wide immunization administration tracking.

27 Oct 2009

Public lecture on "swearing as a response to pain"

Dr Richard Stephens and his colleagues John Atkins and Andrew Kingston found that swearing can increase pain tolerance. Sixty-four undergraduate volunteers were asked to submerge their hand in a tub of ice water for as long as possible while repeating a swear word of their choice; they were then asked to repeat the experiment, this time using a more commonplace word that they would use to describe a table.

27 Oct 2009

Eli Lilly receives access to GeneNews' osteoarthritis genomic biomarker program

GeneNews Limited, a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today announced that it has entered into an agreement allowing Eli Lilly and Company (NYSE: LLY) select access to research from its osteoarthritis genomic biomarker program

27 Oct 2009